Immediate Impact
1 from Science/Nature 63 standout
Citing Papers
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
2024 Standout
Works of Chih‐Lang Lin being referenced
GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial
2022
Diabetes, hepatocellular carcinoma, and mortality in hepatitis C‐infected patients: A population‐based cohort study
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Chih‐Lang Lin | 464 | 405 | 77 | 138 | 82 | 836 | |
| Marco Biolato | 440 | 409 | 128 | 146 | 50 | 929 | |
| Koichi Shiraishi | 354 | 311 | 93 | 148 | 63 | 874 | |
| Irsan Hasan | 555 | 350 | 50 | 135 | 94 | 848 | |
| Yeonjung Ha | 450 | 495 | 108 | 104 | 49 | 806 | |
| Antonio Olveira | 404 | 343 | 64 | 131 | 77 | 932 | |
| Rie Irie | 384 | 281 | 50 | 222 | 55 | 809 | |
| June Sung Lee | 493 | 556 | 86 | 214 | 58 | 888 | |
| Tomoyuki Ninomiya | 416 | 427 | 83 | 234 | 70 | 916 | |
| Cosmas Rinaldi Adithya Lesmana | 639 | 405 | 34 | 275 | 67 | 920 | |
| Tasuku Hara | 687 | 411 | 55 | 173 | 51 | 969 |
All Works
Login with ORCID to disown or claim papers
Loading papers...